Argent BioPharma Limited (ASX:RGT)
0.0810
-0.0040 (-4.71%)
At close: Jun 18, 2025, 4:00 PM AEST
Argent BioPharma Market Cap
Argent BioPharma has a market cap or net worth of 5.85 million as of June 18, 2025. Its market cap has decreased by -66.02% in one year.
Market Cap
5.85M
Enterprise Value
14.48M
Revenue
295.83K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.08
Market Cap Chart
Since September 28, 2012, Argent BioPharma's market cap has increased from 3.12M to 5.85M, an increase of 87.55%. That is a compound annual growth rate of 5.06%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
CSL Limited | 115.78B |
Pro Medicus | 28.66B |
Cochlear | 18.72B |
Sonic Healthcare | 12.87B |
Telix Pharmaceuticals | 8.66B |
Ramsay Health Care | 8.41B |
Ansell | 4.43B |
Mesoblast | 2.38B |